x

Search for a research project

* (*) mandatory field

37 Result(s)

Sort by

Funded by an IRDiRC member =

Research projects

AUSTRIA

WIEN
WIEN

Stat5 serine phosphorylation in Bcr/Abl-induced leukemia
Veterinärmedizinische Universität Wien
Institut für Pharmakologie und Toxikologie

AUSTRIA

WIEN
WIEN

CDK8 - a weapon to arm NK cells against leukemia
Veterinärmedizinische Universität Wien
Institut für Pharmakologie und Toxikologie

BELGIUM

VLAAMS BRABANT
LEUVEN

The role of RAS- and RHO-GTPases, their regulators and mediators in the pathogenesis of myeloid malignancies.
University Hospitals Leuven - Gasthuisberg
Laboratory for Genetics of Malignant Disorders

FRANCE

ILE-DE-FRANCE
ORSAY

ONCOPLURISTEM: models of pluripotent stem cells from chronic myeloid leukemia (CML): generation of new therapeutic tools for screening
Université Paris-Sud
Esteam Pluripotent Stem Cell Core Facility & Ingestem Infrastructure

GERMANY

Baden-Württemberg
MANNHEIM

European Leukemia Net : Chronic myeloblastic leukemia (WP4)
Universitätsklinikum Mannheim
III. Medizinische Klinik - Prof. Hehlmann

GERMANY

Thüringen
JENA

European Leukemia Net : Chronic myeloblastic leukemia (WP4)
Universitätsklinikum Jena
Klinik für Innere Medizin II - Abteilung Hämatologie und Internistische Onkologie

GERMANY

Thüringen
JENA

GERMANY

Thüringen
JENA

Ponderosa: Observational study on CML patients in any phase treated with ponatinib (Iclusig®) at any dose
Universitätsklinikum Jena
Klinik für Innere Medizin II - Abteilung Hämatologie und Internistische Onkologie

ITALY

UMBRIA
PERUGIA

Characterization of chromosomal breakpoints in hematological malignancies using molecular cytogenetics
Università degli Studi di Perugia - Ospedale S. Maria della Misericordia
Laboratorio di Genetica Ematologica e Oncologica

AUSTRIA

WIEN
WIEN

Mechanism of CALR mutants in Myeloproliferative Neoplasms
AKH BT 25.3
Ce-M-M- Research Center for Molecular Medicine of the Austrian Academy of Sciences

AUSTRIA

WIEN
WIEN

Special Research Program - SFB F47 Myleoproliferative Neoplasms
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Hämatologie und Hämostaseologie

FRANCE

ILE-DE-FRANCE
VILLEJUIF

Funded by an IRDiRC memberGERMPN: Study of familial myeloproliferative neoplasms : search for genetic abnormalities and their functions
CLCC Institut Gustave Roussy
Equipe Leucémies myéloïdes chroniques et lymphoïdes

GERMANY

Baden-Württemberg
MANNHEIM

GERMANY

Baden-Württemberg
ULM

Molecular diagnosis of Myeloproliferative Disorders (MPD)
Universitätsklinikum Ulm am Oberen Eselsberg
Klinik für Innere Medizin III

GERMANY

Nordrhein-Westfalen
MINDEN

European Leukemia Net: Observational study - Pregnancy course survey in patients with BCR-ABL-negative chronic myeloproliferative diseases
Johannes Wesling Klinikum Minden
Klinik für Hämatologie, Onkologie und Palliativmedizin

AUSTRIA

WIEN
WIEN

Funded by an IRDiRC memberENCCA: European Network for Cancer Research in Children and Adolescents - UK
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

FRANCE

ILE-DE-FRANCE
VILLEJUIF

Funded by an IRDiRC memberENCCA: EUROPEAN NETWORK for CANCER research in CHILDREN and ADOLESCENTS - FR
CLCC Institut Gustave Roussy
Département de cancérologie de l'enfant et de l'adolescent

FRANCE

ILE-DE-FRANCE
ORSAY

DCD-CANC-CHILD: design of drug carrier and delivery control for cancer therapy of children
Université Paris-Sud
Institut de Chimie Moléculaire et des Matériaux d'Orsay

ITALY

LOMBARDIA
MILANO

RARECARE: surveillance of rare cancers in Europe (coordination)
Fondazione IRCCS Istituto Nazionale dei Tumori
S.S. di Epidemiologia Valutativa

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

EPOC: European paediatric oncology off-patent medicines consortium (coordination)
Northern Institute for Cancer Research, Medical School, Newcastle University
Northern Institute for Cancer Research

Multicentric Research projects